{"gene":"PNP","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1990,"finding":"Human and mammalian purine nucleoside phosphorylase (PNP) requires N1 and O6 of the purine ring as a binding site for phosphorolysis activity, while the bacterial (E. coli) enzyme is less specific. N7-methylation of the purine ring both labilizes the glycosidic bond and impedes protonation at N7, a postulated prerequisite for enzymatic phosphorolysis. A histidine residue is proposed to interact with N1 as a donor and O6 as an acceptor (or alternatively N1-H and C2-NH2 interact with a glutamate residue).","method":"Kinetic analysis of substrate/inhibitor properties (Km, Vmax/Km) using modified nucleoside analogues with mammalian and bacterial PNP enzymes","journal":"Zeitschrift fur Naturforschung. C, Journal of biosciences","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — detailed in vitro kinetics with multiple substrate analogues, single study, mechanistic conclusions partly proposed rather than directly demonstrated by mutagenesis","pmids":["2109978"],"is_preprint":false},{"year":1999,"finding":"Crystal structure of trimeric PNP from Cellulomonas sp. revealed the phosphate binding site (Ser46, Arg103, His105, Gly135, Ser223) and that guanine is recognized via a zig-zag hydrogen-bond pattern through Glu204 (equivalent to Glu201 in human PNP). Glu204 plays the key catalytic role, while Asn246 (Asn243 in mammalian) supports binding of 6-oxopurines rather than catalysis. This mechanism explains why N7-substituted nucleosides are excellent substrates and adenosine lacks substrate activity (due to bridging of O6 via water to Asn246).","method":"X-ray crystallography of binary (enzyme + phosphate) and ternary dead-end (enzyme + phosphate + 8-iodoguanine) complexes at 2.2–2.4 Å resolution","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structures of binary and ternary complexes with functional interpretation, corroborated by known kinetic data on point variants","pmids":["10600382"],"is_preprint":false},{"year":2003,"finding":"Crystal structure of human PNP complexed with the transition-state analog immucillin-H (ImmH) at 2.6 Å resolution established the structural basis for ImmH's high specificity and potency toward human PNP, defining the active-site interactions that differentiate it from non-T-cell targets.","method":"X-ray crystallography using synchrotron radiation","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure at defined resolution, directly correlated with inhibitor specificity for human PNP","pmids":["13679061"],"is_preprint":false},{"year":2003,"finding":"Crystal structure of human PNP in complex with guanine at 2.7 Å resolution refined the purine-binding site residues and explained the structural differences between the apoenzyme, the guanine complex, and the immucillin-H complex, providing a more reliable model for inhibitor design.","method":"X-ray crystallography using synchrotron radiation","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure, compared with multiple related structures in same study","pmids":["14680831"],"is_preprint":false},{"year":2003,"finding":"PNP inhibition (BCX-1777/forodesine) combined with deoxyguanosine kills T-ALL cells by causing a 154-fold accumulation of dGTP (and 8-fold accumulation of dATP). Reversal experiments with deoxycytidine (dCyd) showed that dGTP accumulation, not dATP accumulation, is the primary cytotoxic mechanism. The mechanism involves inhibition of ribonucleotide reductase by dGTP, leading to apoptosis.","method":"Cell proliferation assays, dNTP pool analysis, rescue experiments with dCyd and lamivudine in CEM-SS T-ALL cells","journal":"International immunopharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal biochemical methods (dNTP quantification, rescue experiments), mechanistic pathway established","pmids":["12781704"],"is_preprint":false},{"year":2005,"finding":"Crystal structures of human PNP in complex with guanosine (2.80 Å), 3'-deoxyguanosine (2.86 Å), and 8-azaguanine (2.85 Å) further defined the substrate-binding site and the enzyme's preference for purine nucleosides in the beta-configuration with 6-keto groups.","method":"X-ray crystallography using synchrotron radiation","journal":"Acta crystallographica. Section D, Biological crystallography","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple crystal structures compared in same study","pmids":["15983407"],"is_preprint":false},{"year":2005,"finding":"Crystal structure of human PNP complexed with hypoxanthine at 2.6 Å resolution characterized the intermolecular interactions between the ligand and the active site, contributing to the structural model of the purine-binding site.","method":"X-ray crystallography","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — single crystal structure, single lab","pmids":["15582582"],"is_preprint":false},{"year":2008,"finding":"Tryptophan-free human PNP (Leuko-PNP, with all three Trp residues replaced by Tyr) retains near-normal kinetic properties. Studies with this construct established: (1) guanine bound to PNP adopts the N1H, 6-keto, N7H tautomer as its fluorescent form; (2) phosphate and guanine bind randomly to PNP; (3) ternary complex formation does not involve kinetically significant protein conformational changes (monitored by fluorescence); (4) Tyr88 hydroxyl is not ionized to phenolate when phosphate is bound; (5) the loop region (residues 243–266) near the purine base becomes highly ordered upon substrate/inhibitor binding.","method":"Site-directed mutagenesis (Trp→Tyr substitutions), kinetic analysis, fluorescence spectroscopy, 13C NMR, temperature-jump experiments, X-ray crystallography","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstitution with mutagenesis, multiple orthogonal methods (NMR, fluorescence, crystallography, kinetics) in one rigorous study","pmids":["18269249"],"is_preprint":false},{"year":2013,"finding":"19F-NMR and X-ray crystallography with site-specific 6-fluoro-tryptophan substitutions at His257 or His64 positions in human PNP revealed that the catalytic site loops coexist in multiple conformational states in the phosphate-bound enzyme, and these dynamic conformations become altered or reduced to single conformations upon binding of transition-state analogs or other catalytic site ligands.","method":"19F-NMR with site-specific 6-fluoro-tryptophan labeling combined with X-ray crystallography of multiple complexes","journal":"Chemistry & biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — two orthogonal structural/spectroscopic methods (NMR + crystallography) with multiple ligand complexes in one study","pmids":["23438750"],"is_preprint":false},{"year":1997,"finding":"PNP inhibition (CI-1000) combined with deoxyguanosine causes T-cell death via apoptosis mediated by caspase-3-like protease activation, as evidenced by PARP cleavage (85 kDa fragment), alpha-spectrin cleavage (120 kDa fragment), loss of intact caspase-3, and elevated caspase-3 fluorometric activity. A pan-caspase inhibitor and deoxycytidine (which prevents dGTP accumulation) both blocked cell death and all caspase-3 indicators.","method":"Cell viability assays, Western blotting for PARP and alpha-spectrin cleavage products, fluorometric caspase-3 activity assays, Hoechst nuclear staining, rescue experiments","journal":"Immunopharmacology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods establishing caspase-3-mediated apoptosis as the downstream mechanism of PNP inhibition in T cells","pmids":["9403342"],"is_preprint":false},{"year":2017,"finding":"A missense SNP (rs1049564) in human PNP causes reduced PNP mRNA and protein expression and decreased enzymatic activity even when protein levels are controlled (loss-of-function variant). Homozygous TT lymphoblastoid cells show a 2-fold increase in S-phase cell cycle block that is pharmacologically reversible by hypoxanthine and adenosine, supporting relative PNP deficiency as the cause. The TT genotype also increases type I IFN pathway activation in a dose-response manner.","method":"Lymphoblastoid cell lines with known genotypes, enzyme activity assays, flow cytometry cell cycle analysis, pharmacological rescue with hypoxanthine/adenosine, IFN-induced gene expression assays","journal":"Arthritis & rheumatology (Hoboken, N.J.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods (enzymatic assay, cell cycle, pharmacological rescue) in single study establishing loss-of-function mechanism","pmids":["28859258"],"is_preprint":false},{"year":2006,"finding":"PNP fused to a protein transduction domain (PTD-PNP) rapidly enters PNP-deficient lymphocytes, increases intracellular enzyme activity for up to 96 hours, and is predominantly distributed in the cytoplasm (consistent with endogenous PNP localization). PTD-PNP corrected abnormal T-cell functions including mitogenic response and IL-2 secretion, confirming that PNP is an intracellular cytoplasmic enzyme essential for T-cell purine metabolism.","method":"Protein transduction into PNP-deficient lymphocytes, subcellular fractionation, enzyme activity assays, T-cell functional assays (proliferation, IL-2 secretion)","journal":"Cellular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct subcellular localization by fractionation with functional consequence, T-cell functional correction demonstrated","pmids":["16930574"],"is_preprint":false},{"year":2021,"finding":"In C. elegans, the PNP ortholog pnp-1 acts in intestinal epithelial cells as a negative regulator of the Intracellular Pathogen Response (IPR). Loss of pnp-1 increases resistance to both intracellular and extracellular pathogens. Metabolomics showed pnp-1 enzymatic activity (converting purine nucleosides to free bases) is conserved, and perturbations in purine metabolism are monitored as a host defense cue.","method":"Forward genetic screen, pnp-1 mutant analysis, metabolomics, pathogen resistance assays, IPR gene expression analysis","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype and metabolomics confirmation in C. elegans ortholog","pmids":["33878133"],"is_preprint":false},{"year":2017,"finding":"Human PNP is constitutively released from rat C6 glioma cells into the extracellular medium with similar molecular weight and enzymatic activity to the cytosolic enzyme. Selective activation of P2Y1 or A2A receptors increased extracellular PNP release. Hypoxia decreased released PNP levels (increasing extracellular nucleosides), while re-oxygenation enhanced PNP release, demonstrating that extracellular PNP contributes to purinergic system homeostasis.","method":"Cell culture medium analysis, enzyme activity assays, receptor agonist pharmacology, hypoxia/re-oxygenation experiments","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct detection of extracellular enzyme activity with receptor-mediated regulation, single lab","pmids":["28251649"],"is_preprint":false},{"year":2007,"finding":"Kinetic studies on human erythrocyte PNP showed that the dianionic form of inorganic phosphate (Pi) is the preferred cosubstrate over the monoanionic form, with enzyme efficiency three orders of magnitude higher at pH 8 than pH 5. Both human and E. coli PNP exhibit negative cooperativity in Pi binding (Hill coefficient <1), suggesting allosteric communication between active sites.","method":"Enzyme kinetics across pH 5–8, comparison of phosphate vs thiophosphate as cosubstrate, Hill coefficient analysis","journal":"European biophysics journal : EBJ","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — detailed kinetic characterization, single lab, mechanism partially inferred from kinetics without structural validation","pmids":["17639373"],"is_preprint":false},{"year":2001,"finding":"E. coli PNP binds both the cationic and zwitterionic forms of N7-methylguanosine (m7Guo), with the zwitterion having 3-fold lower affinity. m7Guo binding to E. coli PNP exhibits negative cooperativity (Hill constant <1), in contrast to guanosine binding which is non-cooperative. The product N7-methylguanine is a competitive non-substrate inhibitor (Ki = 8 µM). Fluorescence quenching is a static process, and mean excited-state lifetime is unchanged upon ligand binding.","method":"Steady-state and time-resolved fluorescence spectroscopy, enzyme kinetics, fluorescence quenching analysis","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — detailed in vitro kinetic and spectroscopic characterization, single lab","pmids":["11341918"],"is_preprint":false},{"year":2000,"finding":"E. coli PNP interacts with formycin A (FA) and its N-methyl analogues via fluorescence resonance energy transfer (FRET) from protein tyrosine residues to the FA base moiety. Complex formation with FA shifts the tautomeric equilibrium from the N1-H form to the N2-H form independently of phosphate. With m6FA in the presence of phosphate, an amino-to-imino tautomeric shift occurs with markedly increased affinity (Kd = 0.5 µM vs 46 µM without phosphate), demonstrating that phosphate binding modulates nucleoside binding affinity. Binding stoichiometry is one ligand per native enzyme hexamer.","method":"Steady-state and time-resolved fluorescence spectroscopy, excitation/emission/absorption spectral analysis, Stern-Volmer quenching analysis","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — multiple spectroscopic methods but single lab, mechanistic conclusions about tautomeric shifts inferred from spectra","pmids":["10606773"],"is_preprint":false},{"year":2011,"finding":"miR-1 and miR-133a directly regulate PNP expression in prostate cancer cells, as demonstrated by genome-wide gene expression analysis and luciferase reporter assay. Silencing of PNP gene inhibited proliferation, migration, and invasion of PC3 and DU145 prostate cancer cells, identifying PNP as a functional oncogenic target of these tumor-suppressor miRNAs.","method":"miRNA restoration, genome-wide gene expression analysis, luciferase reporter assay (3'UTR targeting), siRNA-mediated PNP knockdown with proliferation/migration/invasion assays","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase reporter confirms direct miRNA targeting, loss-of-function with defined cellular phenotype, single lab","pmids":["22068816"],"is_preprint":false},{"year":2020,"finding":"SAMHD1 (a dNTP hydrolase) prevents the accumulation of toxic dNTP levels during PNP inhibition, thereby protecting cancer cells from PNP inhibitor-induced cell death. Cancer cells lacking SAMHD1 are selectively killed by PNP inhibitors, establishing SAMHD1 as a resistance factor for PNP inhibitor therapy.","method":"Cell viability assays in SAMHD1-deficient vs proficient cell lines treated with PNP inhibitors","journal":"Molecular & cellular oncology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — cell-based assays establishing pathway relationship, single report, limited mechanistic detail in abstract","pmids":["33235905"],"is_preprint":false}],"current_model":"Human purine nucleoside phosphorylase (PNP) is a homotrimeric cytoplasmic enzyme that catalyzes the phosphorolysis of purine nucleosides (especially 6-oxopurine nucleosides in beta-configuration) to free purine bases and ribose-1-phosphate, using inorganic phosphate (preferentially in its dianionic form) as cosubstrate; the active site Glu201 plays the key catalytic role while a dynamic loop (residues 243–266) orders upon substrate binding, the enzyme exhibits negative cooperativity in phosphate binding, and its activity in T cells is essential for dGTP homeostasis—PNP deficiency or inhibition causes selective T-cell death through dGTP accumulation-triggered caspase-3-mediated apoptosis, a mechanism exploited therapeutically by transition-state analog inhibitors (immucillin-H/forodesine) whose binding is structurally defined by multiple crystal structures."},"narrative":{"mechanistic_narrative":"PNP is a cytoplasmic homotrimeric enzyme that catalyzes the phosphorolysis of 6-oxopurine nucleosides in the beta-configuration, recognizing the N1 and O6 positions of the purine ring as essential determinants of substrate activity, with a conserved active-site glutamate (Glu201, equivalent to Glu204 in the bacterial enzyme) serving the key catalytic role and a neighboring asparagine supporting binding of 6-oxopurines rather than catalysis [PMID:2109978, PMID:10600382, PMID:15983407]. The dianionic form of inorganic phosphate is the preferred cosubstrate, and the enzyme exhibits negative cooperativity in phosphate binding, indicating allosteric communication between active sites [PMID:17639373]. Catalysis is accompanied by ordering of a dynamic loop (residues 243–266) near the purine base upon substrate or inhibitor binding, with active-site loops coexisting in multiple conformational states in the phosphate-bound enzyme that collapse to single conformations upon transition-state-analog binding [PMID:18269249, PMID:23438750]. In T cells, PNP activity is essential for purine metabolism and dGTP homeostasis: enzymatic inhibition combined with deoxyguanosine drives massive dGTP accumulation that inhibits ribonucleotide reductase and triggers caspase-3-mediated apoptosis, selectively killing T-lineage leukemic cells—a vulnerability exploited by transition-state-analog inhibitors such as immucillin-H/forodesine whose binding is defined by human PNP crystal structures [PMID:13679061, PMID:12781704, PMID:9403342]. A loss-of-function PNP variant (rs1049564) produces relative PNP deficiency, an S-phase cell cycle block reversible by hypoxanthine and adenosine, and increased type I interferon pathway activation [PMID:28859258]. Beyond its canonical cytoplasmic role, PNP is constitutively released into the extracellular medium where it contributes to purinergic homeostasis, and the C. elegans ortholog pnp-1 acts in intestinal epithelium as a negative regulator of the intracellular pathogen response [PMID:33878133, PMID:28251649].","teleology":[{"year":1990,"claim":"Established what defines a PNP substrate at the chemical level, explaining the enzyme's strict requirement for 6-oxopurine nucleosides and the basis of substrate discrimination versus the promiscuous bacterial enzyme.","evidence":"Kinetic analysis of modified nucleoside analogues with mammalian and bacterial PNP","pmids":["2109978"],"confidence":"Medium","gaps":["Catalytic residue identities proposed but not confirmed by mutagenesis","No structural model at this stage"]},{"year":1997,"claim":"Defined the terminal effector pathway of PNP inhibition in T cells, showing that cell death proceeds through caspase-3-mediated apoptosis dependent on dGTP accumulation.","evidence":"Western blots for PARP and alpha-spectrin cleavage, caspase-3 activity assays, and deoxycytidine/pan-caspase rescue in T cells treated with CI-1000 plus deoxyguanosine","pmids":["9403342"],"confidence":"High","gaps":["Did not quantify the dNTP pool changes upstream of apoptosis","Did not address selectivity for T cells over other lineages"]},{"year":1999,"claim":"Provided the first structural mechanism for purine recognition and catalysis, identifying the phosphate-binding residues and assigning the catalytic glutamate (Glu204/Glu201) and a binding-supporting asparagine.","evidence":"X-ray crystallography of binary and ternary dead-end complexes of trimeric Cellulomonas PNP at 2.2–2.4 Å","pmids":["10600382"],"confidence":"High","gaps":["Structure from a bacterial homolog rather than human enzyme","Catalytic role inferred from geometry plus prior kinetics"]},{"year":2003,"claim":"Resolved the structural basis of transition-state-analog inhibition and purine binding in the human enzyme, enabling rational inhibitor design.","evidence":"X-ray crystallography of human PNP with immucillin-H and with guanine","pmids":["13679061","14680831"],"confidence":"High","gaps":["Static snapshots did not capture loop dynamics","Did not quantify inhibitor potency in cells"]},{"year":2003,"claim":"Demonstrated that dGTP accumulation, not dATP, is the primary cytotoxic driver of PNP inhibition, mechanistically linking it to ribonucleotide reductase inhibition.","evidence":"dNTP pool analysis and deoxycytidine/lamivudine rescue in CEM-SS T-ALL cells treated with forodesine plus deoxyguanosine","pmids":["12781704"],"confidence":"High","gaps":["Restricted to a single T-ALL line","Did not connect dGTP accumulation to the caspase cascade in the same assay"]},{"year":2005,"claim":"Refined the substrate-binding determinants of human PNP, confirming preference for beta-configuration purine nucleosides with 6-keto groups.","evidence":"X-ray crystallography of human PNP with guanosine, 3'-deoxyguanosine, 8-azaguanine and hypoxanthine complexes","pmids":["15983407","15582582"],"confidence":"High","gaps":["Did not resolve catalytic intermediates","Loop dynamics not characterized"]},{"year":2006,"claim":"Confirmed PNP as an intracellular cytoplasmic enzyme essential for T-cell purine metabolism by restoring function in deficient cells.","evidence":"Protein transduction of PTD-PNP into PNP-deficient lymphocytes with fractionation and T-cell functional assays","pmids":["16930574"],"confidence":"Medium","gaps":["Used an engineered fusion rather than endogenous protein","Single-lab functional correction"]},{"year":2008,"claim":"Characterized the conformational behavior of the active site, showing that the 243–266 loop becomes highly ordered upon ligand binding and that ternary complex formation does not require kinetically significant conformational changes.","evidence":"Tryptophan-free Leuko-PNP construct studied by mutagenesis, fluorescence, 13C NMR, temperature-jump, and crystallography","pmids":["18269249"],"confidence":"High","gaps":["Conducted on an engineered Trp-to-Tyr variant","Did not link loop ordering to catalytic rate enhancement"]},{"year":2007,"claim":"Defined the phosphate cosubstrate chemistry, establishing the dianionic phosphate as preferred and revealing negative cooperativity indicative of inter-subunit allostery.","evidence":"pH-dependent enzyme kinetics and Hill coefficient analysis of human erythrocyte and E. coli PNP","pmids":["17639373"],"confidence":"Medium","gaps":["Allostery inferred from kinetics without structural validation","Single lab"]},{"year":2013,"claim":"Showed that catalytic-site loops sample multiple conformational states in the phosphate-bound enzyme that are selected to single conformations by transition-state analogs, providing a dynamic view of inhibitor action.","evidence":"19F-NMR with site-specific 6-fluoro-tryptophan labeling combined with X-ray crystallography of multiple ligand complexes","pmids":["23438750"],"confidence":"High","gaps":["Required site-specific fluorine labeling","Functional consequence of each conformer not quantified"]},{"year":2017,"claim":"Linked a human loss-of-function PNP variant to cell cycle disruption and innate immune dysregulation, connecting relative PNP deficiency to S-phase block and type I IFN activation.","evidence":"Genotyped lymphoblastoid lines with enzyme assays, flow cytometry, hypoxanthine/adenosine rescue, and IFN gene expression","pmids":["28859258"],"confidence":"Medium","gaps":["Single variant in a cell-line model","Mechanism linking purine deficiency to IFN activation not resolved"]},{"year":2017,"claim":"Identified an extracellular pool of enzymatically active PNP under receptor and oxygen-state control, expanding its role into purinergic system homeostasis.","evidence":"Extracellular enzyme activity detection with P2Y1/A2A agonist pharmacology and hypoxia/re-oxygenation in C6 glioma cells","pmids":["28251649"],"confidence":"Medium","gaps":["Single cell model","Mechanism of release not defined"]},{"year":2011,"claim":"Implicated PNP as a downstream effector of tumor-suppressor miRNAs in prostate cancer, where its expression supports proliferation, migration, and invasion.","evidence":"miR-1/miR-133a restoration, luciferase 3'UTR reporter, and PNP siRNA knockdown with phenotypic assays in PC3/DU145 cells","pmids":["22068816"],"confidence":"Medium","gaps":["Single tumor type and lab","Metabolic mechanism of the oncogenic phenotype not defined"]},{"year":2020,"claim":"Positioned SAMHD1 as a resistance factor that buffers dNTP accumulation during PNP inhibition, defining a synthetic-lethal vulnerability in SAMHD1-deficient cancers.","evidence":"Cell viability assays in SAMHD1-deficient versus proficient lines treated with PNP inhibitors","pmids":["33235905"],"confidence":"Low","gaps":["Single report with limited mechanistic detail","Direct biochemical interaction not demonstrated","Not validated in vivo"]},{"year":null,"claim":"How PNP's purine-base products are decoded as immune and host-defense signals—linking its catalytic output to type I IFN activation and the intracellular pathogen response—remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No defined signaling intermediate connecting purine metabolite levels to IFN induction","Conservation of the host-defense role to mammals untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,5,14]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[0,1,14]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[12,13]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[11]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,4,12]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[4,9]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[10,12]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P01298","full_name":"Pancreatic polypeptide prohormone","aliases":["Pancreatic polypeptide Y"],"length_aa":95,"mass_kda":10.4,"function":"Hormone secreted by pancreatic cells that acts as a regulator of pancreatic and gastrointestinal functions probably by signaling through the G protein-coupled receptor NPY4R2","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P01298/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PNP","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PNP","total_profiled":1310},"omim":[{"mim_id":"621071","title":"MITOCHONDRIAL DNA DEPLETION SYNDROME 21; MTDPS21","url":"https://www.omim.org/entry/621071"},{"mim_id":"618936","title":"SPERMATOGENESIS-ASSOCIATED PROTEIN 25; SPATA25","url":"https://www.omim.org/entry/618936"},{"mim_id":"618560","title":"BETA-1,4-N-ACETYL-GALACTOSAMINYLTRANSFERASE 4; B4GALNT4","url":"https://www.omim.org/entry/618560"},{"mim_id":"613179","title":"PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY","url":"https://www.omim.org/entry/613179"},{"mim_id":"606494","title":"ST3 BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE 3; ST3GAL3","url":"https://www.omim.org/entry/606494"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"bone marrow","ntpm":299.3},{"tissue":"epididymis","ntpm":551.4}],"url":"https://www.proteinatlas.org/search/PNP"},"hgnc":{"alias_symbol":["PUNP"],"prev_symbol":["NP"]},"alphafold":{"accession":"P01298","domains":[{"cath_id":"1.20.5","chopping":"35-64","consensus_level":"medium","plddt":90.14,"start":35,"end":64}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P01298","model_url":"https://alphafold.ebi.ac.uk/files/AF-P01298-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P01298-F1-predicted_aligned_error_v6.png","plddt_mean":76.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PNP","jax_strain_url":"https://www.jax.org/strain/search?query=PNP"},"sequence":{"accession":"P01298","fasta_url":"https://rest.uniprot.org/uniprotkb/P01298.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P01298/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P01298"}},"corpus_meta":[{"pmid":"12434148","id":"PMC_12434148","title":"Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.","date":"2002","source":"Nature structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/12434148","citation_count":444,"is_preprint":false},{"pmid":"18211031","id":"PMC_18211031","title":"Modularly designed transition metal PNP and PCP pincer complexes based on aminophosphines: synthesis and catalytic applications.","date":"2008","source":"Accounts of chemical research","url":"https://pubmed.ncbi.nlm.nih.gov/18211031","citation_count":216,"is_preprint":false},{"pmid":"2459106","id":"PMC_2459106","title":"Stabilization of discrete mRNA breakdown products in ams pnp rnb multiple mutants of Escherichia coli K-12.","date":"1988","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2459106","citation_count":203,"is_preprint":false},{"pmid":"22068816","id":"PMC_22068816","title":"Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer.","date":"2011","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22068816","citation_count":176,"is_preprint":false},{"pmid":"23000901","id":"PMC_23000901","title":"Structure of AMP-PNP-bound vitamin B12 transporter BtuCD-F.","date":"2012","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23000901","citation_count":137,"is_preprint":false},{"pmid":"2432069","id":"PMC_2432069","title":"Nucleotide sequence of the pnp gene of Escherichia coli encoding polynucleotide phosphorylase. Homology of the primary structure of the protein with the RNA-binding domain of ribosomal protein S1.","date":"1987","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2432069","citation_count":102,"is_preprint":false},{"pmid":"7519147","id":"PMC_7519147","title":"Roles of RNase E, RNase II and PNPase in the degradation of the rpsO transcripts of Escherichia coli: stabilizing function of RNase II and evidence for efficient degradation in an ams pnp rnb mutant.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/7519147","citation_count":101,"is_preprint":false},{"pmid":"11726520","id":"PMC_11726520","title":"PNPase autocontrols its expression by degrading a double-stranded structure in the pnp mRNA leader.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11726520","citation_count":90,"is_preprint":false},{"pmid":"2109978","id":"PMC_2109978","title":"Properties of purine nucleoside phosphorylase (PNP) of mammalian and bacterial origin.","date":"1990","source":"Zeitschrift fur Naturforschung. C, Journal of biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/2109978","citation_count":79,"is_preprint":false},{"pmid":"9632258","id":"PMC_9632258","title":"The psychrotrophic bacterium Yersinia enterocolitica requires expression of pnp, the gene for polynucleotide phosphorylase, for growth at low temperature (5 degrees C).","date":"1998","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/9632258","citation_count":79,"is_preprint":false},{"pmid":"7877458","id":"PMC_7877458","title":"Localization of phosphoneuroprotein 14 (PNP 14) and its mRNA expression in rat brain determined by immunocytochemistry and in situ hybridization.","date":"1994","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/7877458","citation_count":75,"is_preprint":false},{"pmid":"24611673","id":"PMC_24611673","title":"Catalytic mechanisms of direct pyrrole synthesis via dehydrogenative coupling mediated by PNP-Ir or PNN-Ru pincer complexes: crucial role of proton-transfer shuttles in the PNP-Ir system.","date":"2014","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/24611673","citation_count":71,"is_preprint":false},{"pmid":"12964162","id":"PMC_12964162","title":"NMR chemical shift perturbation study of the N-terminal domain of Hsp90 upon binding of ADP, AMP-PNP, geldanamycin, and radicicol.","date":"2003","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/12964162","citation_count":69,"is_preprint":false},{"pmid":"12781704","id":"PMC_12781704","title":"Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777.","date":"2003","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12781704","citation_count":67,"is_preprint":false},{"pmid":"10600382","id":"PMC_10600382","title":"Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10600382","citation_count":58,"is_preprint":false},{"pmid":"20486648","id":"PMC_20486648","title":"Ruthenium complexes with cooperative PNP-pincer amine, amido, imine, and enamido ligands: facile ligand backbone functionalization processes.","date":"2010","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20486648","citation_count":57,"is_preprint":false},{"pmid":"13679061","id":"PMC_13679061","title":"Structural basis for inhibition of human PNP by immucillin-H.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/13679061","citation_count":53,"is_preprint":false},{"pmid":"25402482","id":"PMC_25402482","title":"Structure of AMP-PNP-bound BtuCD and mechanism of ATP-powered vitamin B12 transport by BtuCD-F.","date":"2014","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25402482","citation_count":51,"is_preprint":false},{"pmid":"33878133","id":"PMC_33878133","title":"The purine nucleoside phosphorylase pnp-1 regulates epithelial cell resistance to infection in C. elegans.","date":"2021","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/33878133","citation_count":50,"is_preprint":false},{"pmid":"15983407","id":"PMC_15983407","title":"Structure of human PNP complexed with ligands.","date":"2005","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/15983407","citation_count":48,"is_preprint":false},{"pmid":"6382163","id":"PMC_6382163","title":"Expression of the rpsO and pnp genes: structural analysis of a DNA fragment carrying their control regions.","date":"1984","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/6382163","citation_count":47,"is_preprint":false},{"pmid":"14680831","id":"PMC_14680831","title":"Crystal structure of human PNP complexed with guanine.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14680831","citation_count":47,"is_preprint":false},{"pmid":"7516438","id":"PMC_7516438","title":"Nucleolytic inactivation and degradation of the RNase III processed pnp message encoding polynucleotide phosphorylase of Escherichia coli.","date":"1994","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7516438","citation_count":46,"is_preprint":false},{"pmid":"17965184","id":"PMC_17965184","title":"Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP.","date":"2007","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/17965184","citation_count":44,"is_preprint":false},{"pmid":"8672447","id":"PMC_8672447","title":"Structure of the R65Q mutant of yeast 3-phosphoglycerate kinase complexed with Mg-AMP-PNP and 3-phospho-D-glycerate.","date":"1996","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8672447","citation_count":43,"is_preprint":false},{"pmid":"15610008","id":"PMC_15610008","title":"Crystal structures of Escherichia coli RecA in complex with MgADP and MnAMP-PNP.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15610008","citation_count":43,"is_preprint":false},{"pmid":"20695479","id":"PMC_20695479","title":"Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening.","date":"2010","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/20695479","citation_count":42,"is_preprint":false},{"pmid":"6276682","id":"PMC_6276682","title":"Cloning of E. coli pnp gene from an episome.","date":"1981","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/6276682","citation_count":40,"is_preprint":false},{"pmid":"24948692","id":"PMC_24948692","title":"Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous T-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome).","date":"2014","source":"Annals of oncology : official journal of the European Society for Medical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24948692","citation_count":38,"is_preprint":false},{"pmid":"11453975","id":"PMC_11453975","title":"Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient.","date":"2001","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11453975","citation_count":38,"is_preprint":false},{"pmid":"31390860","id":"PMC_31390860","title":"Thermodynamic Analysis of Metal-Ligand Cooperativity of PNP Ru Complexes: Implications for CO2 Hydrogenation to Methanol and Catalyst Inhibition.","date":"2019","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/31390860","citation_count":36,"is_preprint":false},{"pmid":"10606773","id":"PMC_10606773","title":"Formycin A and its N-methyl analogues, specific inhibitors of E. coli purine nucleoside phosphorylase (PNP): induced tautomeric shifts on binding to enzyme, and enzyme-->ligand fluorescence resonance energy transfer.","date":"2000","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10606773","citation_count":35,"is_preprint":false},{"pmid":"30308370","id":"PMC_30308370","title":"Simultaneous p-nitrophenol and nitrogen removal in PNP wastewater treatment: Comparison of two integrated membrane-aerated bioreactor systems.","date":"2018","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/30308370","citation_count":34,"is_preprint":false},{"pmid":"26597175","id":"PMC_26597175","title":"Structures of the CDK12/CycK complex with AMP-PNP reveal a flexible C-terminal kinase extension important for ATP binding.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26597175","citation_count":34,"is_preprint":false},{"pmid":"15520787","id":"PMC_15520787","title":"Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation.","date":"2004","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/15520787","citation_count":34,"is_preprint":false},{"pmid":"17968024","id":"PMC_17968024","title":"Two distinct modes of processive kinesin movement in mixtures of ATP and AMP-PNP.","date":"2007","source":"The Journal of general physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17968024","citation_count":33,"is_preprint":false},{"pmid":"32409317","id":"PMC_32409317","title":"PLANT NATRIURETIC PEPTIDE A and Its Putative Receptor PNP-R2 Antagonize Salicylic Acid-Mediated Signaling and Cell Death.","date":"2020","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/32409317","citation_count":32,"is_preprint":false},{"pmid":"16305530","id":"PMC_16305530","title":"PNP anticancer gene therapy.","date":"2005","source":"Current topics in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16305530","citation_count":31,"is_preprint":false},{"pmid":"36867088","id":"PMC_36867088","title":"Versatile CO2 Hydrogenation-Dehydrogenation Catalysis with a Ru-PNP/Ionic Liquid System.","date":"2023","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/36867088","citation_count":31,"is_preprint":false},{"pmid":"3029034","id":"PMC_3029034","title":"Tn5 insertion in the polynucleotide phosphorylase (pnp) gene in Escherichia coli increases susceptibility to antibiotics.","date":"1987","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/3029034","citation_count":31,"is_preprint":false},{"pmid":"14624640","id":"PMC_14624640","title":"The [(99m)Tc(N)(PNP)](2+) metal fragment: a technetium-nitrido synthon for use with biologically active molecules. The N-(2-methoxyphenyl)piperazyl-cysteine analogues as examples.","date":"2003","source":"Bioconjugate chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14624640","citation_count":31,"is_preprint":false},{"pmid":"26438818","id":"PMC_26438818","title":"CsrA Participates in a PNPase Autoregulatory Mechanism by Selectively Repressing Translation of pnp Transcripts That Have Been Previously Processed by RNase III and PNPase.","date":"2015","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/26438818","citation_count":29,"is_preprint":false},{"pmid":"1691434","id":"PMC_1691434","title":"Escherichia coli glyA mRNA decay: the role of 3' secondary structure and the effects of the pnp and rnb mutations.","date":"1990","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/1691434","citation_count":29,"is_preprint":false},{"pmid":"18381241","id":"PMC_18381241","title":"Molecular modeling and dynamics simulations of PNP from Streptococcus agalactiae.","date":"2008","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18381241","citation_count":29,"is_preprint":false},{"pmid":"22322961","id":"PMC_22322961","title":"Involvement of pnp in survival of UV radiation in Escherichia coli K-12.","date":"2012","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/22322961","citation_count":28,"is_preprint":false},{"pmid":"15313179","id":"PMC_15313179","title":"Structural bioinformatics study of PNP from Schistosoma mansoni.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15313179","citation_count":28,"is_preprint":false},{"pmid":"15582582","id":"PMC_15582582","title":"Crystal structure of human PNP complexed with hypoxanthine and sulfate ion.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15582582","citation_count":27,"is_preprint":false},{"pmid":"9144554","id":"PMC_9144554","title":"Inhibition of ecto-ATPase by the P2 purinoceptor agonists, ATPgammaS, alpha,beta-methylene-ATP, and AMP-PNP, in endothelial cells.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9144554","citation_count":27,"is_preprint":false},{"pmid":"16076842","id":"PMC_16076842","title":"The absB gene encodes a double strand-specific endoribonuclease that cleaves the read-through transcript of the rpsO-pnp operon in Streptomyces coelicolor.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16076842","citation_count":27,"is_preprint":false},{"pmid":"12904557","id":"PMC_12904557","title":"Overexpression of the polynucleotide phosphorylase gene (pnp) of Streptomyces antibioticus affects mRNA stability and poly(A) tail length but not ppGpp levels.","date":"2003","source":"Microbiology (Reading, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12904557","citation_count":25,"is_preprint":false},{"pmid":"18269249","id":"PMC_18269249","title":"Tryptophan-free human PNP reveals catalytic site interactions.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18269249","citation_count":25,"is_preprint":false},{"pmid":"2414737","id":"PMC_2414737","title":"Attenuation and processing of RNA from the rpsO-pnp transcription unit of Escherichia coli.","date":"1985","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2414737","citation_count":24,"is_preprint":false},{"pmid":"22681853","id":"PMC_22681853","title":"Branching of the p-nitrophenol (PNP) degradation pathway in burkholderia sp. Strain SJ98: Evidences from genetic characterization of PNP gene cluster.","date":"2012","source":"AMB Express","url":"https://pubmed.ncbi.nlm.nih.gov/22681853","citation_count":24,"is_preprint":false},{"pmid":"15812229","id":"PMC_15812229","title":"Antibiotic-mediated chemoprotection enhances adaptation of E. coli PNP for herpes simplex virus-based glioma therapy.","date":"2005","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/15812229","citation_count":24,"is_preprint":false},{"pmid":"28859258","id":"PMC_28859258","title":"Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.","date":"2017","source":"Arthritis & rheumatology (Hoboken, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/28859258","citation_count":22,"is_preprint":false},{"pmid":"16930574","id":"PMC_16930574","title":"Intracellular delivery of purine nucleoside phosphorylase (PNP) fused to protein transduction domain corrects PNP deficiency in vitro.","date":"2006","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16930574","citation_count":22,"is_preprint":false},{"pmid":"8437847","id":"PMC_8437847","title":"Differences in the interaction of p21c-Ha-ras-GMP-PNP with full-length neurofibromin and GTPase-activating protein.","date":"1993","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8437847","citation_count":22,"is_preprint":false},{"pmid":"9001721","id":"PMC_9001721","title":"Distribution of phosphoneuroprotein 14 (PNP 14) in vertebrates: its levels as determined by enzyme immunoassay.","date":"1996","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9001721","citation_count":22,"is_preprint":false},{"pmid":"8931706","id":"PMC_8931706","title":"Two novel missense and frameshift mutations in exons 5 and 6 of the purine nucleoside phosphorylase (PNP) gene in a severe combined immunodeficiency (SCID) patient.","date":"1996","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8931706","citation_count":21,"is_preprint":false},{"pmid":"27924345","id":"PMC_27924345","title":"Chemoenzymatic synthesis of para-nitrophenol (pNP)-tagged α2-8-sialosides and high-throughput substrate specificity studies of α2-8-sialidases.","date":"2016","source":"Organic & biomolecular chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27924345","citation_count":21,"is_preprint":false},{"pmid":"31002499","id":"PMC_31002499","title":"Square Planar Cobalt(II) Hydride versus T-Shaped Cobalt(I): Structural Characterization and Dihydrogen Activation with PNP-Cobalt Pincer Complexes.","date":"2019","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31002499","citation_count":21,"is_preprint":false},{"pmid":"12062428","id":"PMC_12062428","title":"Evidence that the putative alpha-glucosidase of Thermotoga maritima MSB8 is a pNP alpha-D-glucuronopyranoside hydrolyzing alpha-glucuronidase.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12062428","citation_count":20,"is_preprint":false},{"pmid":"15126478","id":"PMC_15126478","title":"Organization and expression of the polynucleotide phosphorylase gene (pnp) of Streptomyces: Processing of pnp transcripts in Streptomyces antibioticus.","date":"2004","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/15126478","citation_count":19,"is_preprint":false},{"pmid":"29718963","id":"PMC_29718963","title":"An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29718963","citation_count":18,"is_preprint":false},{"pmid":"32196320","id":"PMC_32196320","title":"Ru0 or RuII: A Study on Stabilizing the \"Activated\" Form of Ru-PNP Complexes with Additional Phosphine Ligands in Alcohol Dehydrogenation and Ester Hydrogenation.","date":"2020","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32196320","citation_count":18,"is_preprint":false},{"pmid":"2698890","id":"PMC_2698890","title":"Characterization of mitotic motors by their relative sensitivity to AMP-PNP.","date":"1989","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/2698890","citation_count":16,"is_preprint":false},{"pmid":"11915","id":"PMC_11915","title":"Catecholamine-sensitive adenylate cyclase of human fat cell ghosts. Characteristics of the GMP(PNP)-liganded state.","date":"1976","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11915","citation_count":16,"is_preprint":false},{"pmid":"17591551","id":"PMC_17591551","title":"Avidin-biotin system: a small library of cysteine biotinylated derivatives designed for the [99mTc(N)(PNP)]2+ metal fragment.","date":"2007","source":"Nuclear medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/17591551","citation_count":16,"is_preprint":false},{"pmid":"21742867","id":"PMC_21742867","title":"RNase III-dependent expression of the rpsO-pnp operon of Streptomyces coelicolor.","date":"2011","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/21742867","citation_count":15,"is_preprint":false},{"pmid":"17544667","id":"PMC_17544667","title":"Synthesis and biological evaluation of 9-deazaguanine derivatives connected by a linker to difluoromethylene phosphonic acid as multi-substrate analogue inhibitors of PNP.","date":"2007","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/17544667","citation_count":15,"is_preprint":false},{"pmid":"23438750","id":"PMC_23438750","title":"Catalytic site conformations in human PNP by 19F-NMR and crystallography.","date":"2013","source":"Chemistry & biology","url":"https://pubmed.ncbi.nlm.nih.gov/23438750","citation_count":14,"is_preprint":false},{"pmid":"18585465","id":"PMC_18585465","title":"Overexpression, purification and characterization of functional calf purine nucleoside phosphorylase (PNP).","date":"2008","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/18585465","citation_count":13,"is_preprint":false},{"pmid":"17016779","id":"PMC_17016779","title":"Drug evaluation: forodesine - PNP inhibitor for the treatment of leukemia, lymphoma and solid tumor.","date":"2006","source":"IDrugs : the investigational drugs journal","url":"https://pubmed.ncbi.nlm.nih.gov/17016779","citation_count":13,"is_preprint":false},{"pmid":"28251649","id":"PMC_28251649","title":"Evidence for purine nucleoside phosphorylase (PNP) release from rat C6 glioma cells.","date":"2017","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28251649","citation_count":13,"is_preprint":false},{"pmid":"33235905","id":"PMC_33235905","title":"PNP inhibitors selectively kill cancer cells lacking SAMHD1.","date":"2020","source":"Molecular & cellular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33235905","citation_count":13,"is_preprint":false},{"pmid":"789366","id":"PMC_789366","title":"Further studies on the isolation and properties of polyriboadenylate polymerase from Escherichia coli PR7 (RNase I-, pnp).","date":"1976","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/789366","citation_count":13,"is_preprint":false},{"pmid":"9918502","id":"PMC_9918502","title":"7-Deazapurine 2'-deoxyribofuranosides are noncleavable competitive inhibitors of Escherichia coli purine nucleoside phosphorylase (PNP).","date":"1998","source":"Acta biochimica Polonica","url":"https://pubmed.ncbi.nlm.nih.gov/9918502","citation_count":13,"is_preprint":false},{"pmid":"28570923","id":"PMC_28570923","title":"4-Nitrophenol (PNP) inhibits the expression of estrogen receptor β and disrupts steroidogenesis during the ovarian development in female rats.","date":"2017","source":"Environmental pollution (Barking, Essex : 1987)","url":"https://pubmed.ncbi.nlm.nih.gov/28570923","citation_count":12,"is_preprint":false},{"pmid":"7876563","id":"PMC_7876563","title":"Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression.","date":"1995","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7876563","citation_count":12,"is_preprint":false},{"pmid":"31707514","id":"PMC_31707514","title":"The Broad Clinical Spectrum and Transplant Results of PNP Deficiency.","date":"2019","source":"Journal of clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31707514","citation_count":11,"is_preprint":false},{"pmid":"2119794","id":"PMC_2119794","title":"Inhibition of the enzyme purine nucleoside phosphorylase (PNP) reduces refractoriness to transfused platelets in a dog model.","date":"1990","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/2119794","citation_count":11,"is_preprint":false},{"pmid":"7589453","id":"PMC_7589453","title":"Influence of ADP, AMP-PNP and of depletion of nucleotides on the structural properties of F1ATPase: a Fourier transform infrared spectroscopic study.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7589453","citation_count":11,"is_preprint":false},{"pmid":"19636960","id":"PMC_19636960","title":"Backbone NMR resonance assignment of the catalytic subunit of cAMP-dependent protein kinase A in complex with AMP-PNP.","date":"2009","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/19636960","citation_count":11,"is_preprint":false},{"pmid":"17639373","id":"PMC_17639373","title":"Role of ionization of the phosphate cosubstrate on phosphorolysis by purine nucleoside phosphorylase (PNP) of bacterial (E. coli) and mammalian (human) origin.","date":"2007","source":"European biophysics journal : EBJ","url":"https://pubmed.ncbi.nlm.nih.gov/17639373","citation_count":11,"is_preprint":false},{"pmid":"17269133","id":"PMC_17269133","title":"The [Tc(N)(PNP)]2+ metal fragment labeled cholecystokinin-8 (CCK8) peptide for CCK-2 receptors imaging: in vitro and in vivo studies.","date":"2007","source":"Journal of peptide science : an official publication of the European Peptide Society","url":"https://pubmed.ncbi.nlm.nih.gov/17269133","citation_count":11,"is_preprint":false},{"pmid":"31708232","id":"PMC_31708232","title":"In vitro effects of PNP and PNMC on apoptosis and proliferation in the hen ovarian stroma and prehierarchal follicles.","date":"2019","source":"Acta histochemica","url":"https://pubmed.ncbi.nlm.nih.gov/31708232","citation_count":10,"is_preprint":false},{"pmid":"6794677","id":"PMC_6794677","title":"Purine nucleoside phosphorylase (PNP) and adenosine deaminase (ADA) activities examined cytochemically in unfixed lymphocytes of patients with lymphoproliferative disorders.","date":"1981","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/6794677","citation_count":10,"is_preprint":false},{"pmid":"34898806","id":"PMC_34898806","title":"Effect of Pincer Methylation on the Selectivity and Activity in (PNP)Cobalt-Catalyzed C(sp2)-H Borylation.","date":"2021","source":"Organometallics","url":"https://pubmed.ncbi.nlm.nih.gov/34898806","citation_count":10,"is_preprint":false},{"pmid":"1530976","id":"PMC_1530976","title":"The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).","date":"1992","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/1530976","citation_count":10,"is_preprint":false},{"pmid":"1371867","id":"PMC_1371867","title":"Processing in the 5' region of the pnp transcript facilitates the site-specific endonucleolytic cleavages of mRNA.","date":"1992","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1371867","citation_count":10,"is_preprint":false},{"pmid":"37263467","id":"PMC_37263467","title":"Detoxification of p-nitrophenol (PNP) using Enterococcus gallinarum JT-02 isolated from animal farm waste sludge.","date":"2023","source":"Environmental research","url":"https://pubmed.ncbi.nlm.nih.gov/37263467","citation_count":9,"is_preprint":false},{"pmid":"34990130","id":"PMC_34990130","title":"Rare-Earth-Metal Complexes Bearing an Iminodibenzyl-PNP Pincer Ligand: Synthesis and Reactivity toward 3,4-Selective Polymerization of 1,3-Dienes.","date":"2022","source":"Inorganic chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34990130","citation_count":9,"is_preprint":false},{"pmid":"34698070","id":"PMC_34698070","title":"Early Diagnosis and Treatment of Purine Nucleoside Phosphorylase (PNP) Deficiency through TREC-Based Newborn Screening.","date":"2021","source":"International journal of neonatal screening","url":"https://pubmed.ncbi.nlm.nih.gov/34698070","citation_count":9,"is_preprint":false},{"pmid":"30495949","id":"PMC_30495949","title":"[99mTc][Tc(N)(DASD)(PNP n)]+ (DASD = 1,4-Dioxa-8-azaspiro[4,5]decandithiocarbamate, PNP n = Bisphosphinoamine) for Myocardial Imaging: Synthesis, Pharmacological and Pharmacokinetic Studies.","date":"2018","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30495949","citation_count":9,"is_preprint":false},{"pmid":"16269906","id":"PMC_16269906","title":"Bone mass and strength: phenotypic and genetic relationship to alcohol preference in P/NP and HAD/LAD rats.","date":"2005","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/16269906","citation_count":9,"is_preprint":false},{"pmid":"11341918","id":"PMC_11341918","title":"Interaction of Escherichia coli purine nucleoside phosphorylase (PNP) with the cationic and zwitterionic forms of the fluorescent substrate N(7)-methylguanosine.","date":"2001","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/11341918","citation_count":9,"is_preprint":false},{"pmid":"22669887","id":"PMC_22669887","title":"Purine nucleoside phosphorylase deficiency with a novel PNP gene mutation: a first case report from India.","date":"2011","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/22669887","citation_count":9,"is_preprint":false},{"pmid":"24811620","id":"PMC_24811620","title":"Ionic size effects to molecular solvation energy and to ion current across a channel resulted from the nonuniform size-modified PNP equations.","date":"2014","source":"The Journal of chemical physics","url":"https://pubmed.ncbi.nlm.nih.gov/24811620","citation_count":9,"is_preprint":false},{"pmid":"10947174","id":"PMC_10947174","title":"Hereditary persistent right oviduct in the chicken PNP/DO line.","date":"2000","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/10947174","citation_count":8,"is_preprint":false},{"pmid":"9403342","id":"PMC_9403342","title":"A purine nucleoside phosphorylase (PNP) inhibitor induces apoptosis via caspase-3-like protease activity in MOLT-4 T cells.","date":"1997","source":"Immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/9403342","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48749,"output_tokens":5122,"usd":0.111538,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13499,"output_tokens":4471,"usd":0.089635,"stage2_stop_reason":"end_turn"},"total_usd":0.201173,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"Human and mammalian purine nucleoside phosphorylase (PNP) requires N1 and O6 of the purine ring as a binding site for phosphorolysis activity, while the bacterial (E. coli) enzyme is less specific. N7-methylation of the purine ring both labilizes the glycosidic bond and impedes protonation at N7, a postulated prerequisite for enzymatic phosphorolysis. A histidine residue is proposed to interact with N1 as a donor and O6 as an acceptor (or alternatively N1-H and C2-NH2 interact with a glutamate residue).\",\n      \"method\": \"Kinetic analysis of substrate/inhibitor properties (Km, Vmax/Km) using modified nucleoside analogues with mammalian and bacterial PNP enzymes\",\n      \"journal\": \"Zeitschrift fur Naturforschung. C, Journal of biosciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — detailed in vitro kinetics with multiple substrate analogues, single study, mechanistic conclusions partly proposed rather than directly demonstrated by mutagenesis\",\n      \"pmids\": [\"2109978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Crystal structure of trimeric PNP from Cellulomonas sp. revealed the phosphate binding site (Ser46, Arg103, His105, Gly135, Ser223) and that guanine is recognized via a zig-zag hydrogen-bond pattern through Glu204 (equivalent to Glu201 in human PNP). Glu204 plays the key catalytic role, while Asn246 (Asn243 in mammalian) supports binding of 6-oxopurines rather than catalysis. This mechanism explains why N7-substituted nucleosides are excellent substrates and adenosine lacks substrate activity (due to bridging of O6 via water to Asn246).\",\n      \"method\": \"X-ray crystallography of binary (enzyme + phosphate) and ternary dead-end (enzyme + phosphate + 8-iodoguanine) complexes at 2.2–2.4 Å resolution\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structures of binary and ternary complexes with functional interpretation, corroborated by known kinetic data on point variants\",\n      \"pmids\": [\"10600382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Crystal structure of human PNP complexed with the transition-state analog immucillin-H (ImmH) at 2.6 Å resolution established the structural basis for ImmH's high specificity and potency toward human PNP, defining the active-site interactions that differentiate it from non-T-cell targets.\",\n      \"method\": \"X-ray crystallography using synchrotron radiation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure at defined resolution, directly correlated with inhibitor specificity for human PNP\",\n      \"pmids\": [\"13679061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Crystal structure of human PNP in complex with guanine at 2.7 Å resolution refined the purine-binding site residues and explained the structural differences between the apoenzyme, the guanine complex, and the immucillin-H complex, providing a more reliable model for inhibitor design.\",\n      \"method\": \"X-ray crystallography using synchrotron radiation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure, compared with multiple related structures in same study\",\n      \"pmids\": [\"14680831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PNP inhibition (BCX-1777/forodesine) combined with deoxyguanosine kills T-ALL cells by causing a 154-fold accumulation of dGTP (and 8-fold accumulation of dATP). Reversal experiments with deoxycytidine (dCyd) showed that dGTP accumulation, not dATP accumulation, is the primary cytotoxic mechanism. The mechanism involves inhibition of ribonucleotide reductase by dGTP, leading to apoptosis.\",\n      \"method\": \"Cell proliferation assays, dNTP pool analysis, rescue experiments with dCyd and lamivudine in CEM-SS T-ALL cells\",\n      \"journal\": \"International immunopharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal biochemical methods (dNTP quantification, rescue experiments), mechanistic pathway established\",\n      \"pmids\": [\"12781704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structures of human PNP in complex with guanosine (2.80 Å), 3'-deoxyguanosine (2.86 Å), and 8-azaguanine (2.85 Å) further defined the substrate-binding site and the enzyme's preference for purine nucleosides in the beta-configuration with 6-keto groups.\",\n      \"method\": \"X-ray crystallography using synchrotron radiation\",\n      \"journal\": \"Acta crystallographica. Section D, Biological crystallography\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple crystal structures compared in same study\",\n      \"pmids\": [\"15983407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Crystal structure of human PNP complexed with hypoxanthine at 2.6 Å resolution characterized the intermolecular interactions between the ligand and the active site, contributing to the structural model of the purine-binding site.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — single crystal structure, single lab\",\n      \"pmids\": [\"15582582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Tryptophan-free human PNP (Leuko-PNP, with all three Trp residues replaced by Tyr) retains near-normal kinetic properties. Studies with this construct established: (1) guanine bound to PNP adopts the N1H, 6-keto, N7H tautomer as its fluorescent form; (2) phosphate and guanine bind randomly to PNP; (3) ternary complex formation does not involve kinetically significant protein conformational changes (monitored by fluorescence); (4) Tyr88 hydroxyl is not ionized to phenolate when phosphate is bound; (5) the loop region (residues 243–266) near the purine base becomes highly ordered upon substrate/inhibitor binding.\",\n      \"method\": \"Site-directed mutagenesis (Trp→Tyr substitutions), kinetic analysis, fluorescence spectroscopy, 13C NMR, temperature-jump experiments, X-ray crystallography\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstitution with mutagenesis, multiple orthogonal methods (NMR, fluorescence, crystallography, kinetics) in one rigorous study\",\n      \"pmids\": [\"18269249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"19F-NMR and X-ray crystallography with site-specific 6-fluoro-tryptophan substitutions at His257 or His64 positions in human PNP revealed that the catalytic site loops coexist in multiple conformational states in the phosphate-bound enzyme, and these dynamic conformations become altered or reduced to single conformations upon binding of transition-state analogs or other catalytic site ligands.\",\n      \"method\": \"19F-NMR with site-specific 6-fluoro-tryptophan labeling combined with X-ray crystallography of multiple complexes\",\n      \"journal\": \"Chemistry & biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — two orthogonal structural/spectroscopic methods (NMR + crystallography) with multiple ligand complexes in one study\",\n      \"pmids\": [\"23438750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PNP inhibition (CI-1000) combined with deoxyguanosine causes T-cell death via apoptosis mediated by caspase-3-like protease activation, as evidenced by PARP cleavage (85 kDa fragment), alpha-spectrin cleavage (120 kDa fragment), loss of intact caspase-3, and elevated caspase-3 fluorometric activity. A pan-caspase inhibitor and deoxycytidine (which prevents dGTP accumulation) both blocked cell death and all caspase-3 indicators.\",\n      \"method\": \"Cell viability assays, Western blotting for PARP and alpha-spectrin cleavage products, fluorometric caspase-3 activity assays, Hoechst nuclear staining, rescue experiments\",\n      \"journal\": \"Immunopharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods establishing caspase-3-mediated apoptosis as the downstream mechanism of PNP inhibition in T cells\",\n      \"pmids\": [\"9403342\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"A missense SNP (rs1049564) in human PNP causes reduced PNP mRNA and protein expression and decreased enzymatic activity even when protein levels are controlled (loss-of-function variant). Homozygous TT lymphoblastoid cells show a 2-fold increase in S-phase cell cycle block that is pharmacologically reversible by hypoxanthine and adenosine, supporting relative PNP deficiency as the cause. The TT genotype also increases type I IFN pathway activation in a dose-response manner.\",\n      \"method\": \"Lymphoblastoid cell lines with known genotypes, enzyme activity assays, flow cytometry cell cycle analysis, pharmacological rescue with hypoxanthine/adenosine, IFN-induced gene expression assays\",\n      \"journal\": \"Arthritis & rheumatology (Hoboken, N.J.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods (enzymatic assay, cell cycle, pharmacological rescue) in single study establishing loss-of-function mechanism\",\n      \"pmids\": [\"28859258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PNP fused to a protein transduction domain (PTD-PNP) rapidly enters PNP-deficient lymphocytes, increases intracellular enzyme activity for up to 96 hours, and is predominantly distributed in the cytoplasm (consistent with endogenous PNP localization). PTD-PNP corrected abnormal T-cell functions including mitogenic response and IL-2 secretion, confirming that PNP is an intracellular cytoplasmic enzyme essential for T-cell purine metabolism.\",\n      \"method\": \"Protein transduction into PNP-deficient lymphocytes, subcellular fractionation, enzyme activity assays, T-cell functional assays (proliferation, IL-2 secretion)\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct subcellular localization by fractionation with functional consequence, T-cell functional correction demonstrated\",\n      \"pmids\": [\"16930574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In C. elegans, the PNP ortholog pnp-1 acts in intestinal epithelial cells as a negative regulator of the Intracellular Pathogen Response (IPR). Loss of pnp-1 increases resistance to both intracellular and extracellular pathogens. Metabolomics showed pnp-1 enzymatic activity (converting purine nucleosides to free bases) is conserved, and perturbations in purine metabolism are monitored as a host defense cue.\",\n      \"method\": \"Forward genetic screen, pnp-1 mutant analysis, metabolomics, pathogen resistance assays, IPR gene expression analysis\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined cellular phenotype and metabolomics confirmation in C. elegans ortholog\",\n      \"pmids\": [\"33878133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human PNP is constitutively released from rat C6 glioma cells into the extracellular medium with similar molecular weight and enzymatic activity to the cytosolic enzyme. Selective activation of P2Y1 or A2A receptors increased extracellular PNP release. Hypoxia decreased released PNP levels (increasing extracellular nucleosides), while re-oxygenation enhanced PNP release, demonstrating that extracellular PNP contributes to purinergic system homeostasis.\",\n      \"method\": \"Cell culture medium analysis, enzyme activity assays, receptor agonist pharmacology, hypoxia/re-oxygenation experiments\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct detection of extracellular enzyme activity with receptor-mediated regulation, single lab\",\n      \"pmids\": [\"28251649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Kinetic studies on human erythrocyte PNP showed that the dianionic form of inorganic phosphate (Pi) is the preferred cosubstrate over the monoanionic form, with enzyme efficiency three orders of magnitude higher at pH 8 than pH 5. Both human and E. coli PNP exhibit negative cooperativity in Pi binding (Hill coefficient <1), suggesting allosteric communication between active sites.\",\n      \"method\": \"Enzyme kinetics across pH 5–8, comparison of phosphate vs thiophosphate as cosubstrate, Hill coefficient analysis\",\n      \"journal\": \"European biophysics journal : EBJ\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — detailed kinetic characterization, single lab, mechanism partially inferred from kinetics without structural validation\",\n      \"pmids\": [\"17639373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"E. coli PNP binds both the cationic and zwitterionic forms of N7-methylguanosine (m7Guo), with the zwitterion having 3-fold lower affinity. m7Guo binding to E. coli PNP exhibits negative cooperativity (Hill constant <1), in contrast to guanosine binding which is non-cooperative. The product N7-methylguanine is a competitive non-substrate inhibitor (Ki = 8 µM). Fluorescence quenching is a static process, and mean excited-state lifetime is unchanged upon ligand binding.\",\n      \"method\": \"Steady-state and time-resolved fluorescence spectroscopy, enzyme kinetics, fluorescence quenching analysis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — detailed in vitro kinetic and spectroscopic characterization, single lab\",\n      \"pmids\": [\"11341918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"E. coli PNP interacts with formycin A (FA) and its N-methyl analogues via fluorescence resonance energy transfer (FRET) from protein tyrosine residues to the FA base moiety. Complex formation with FA shifts the tautomeric equilibrium from the N1-H form to the N2-H form independently of phosphate. With m6FA in the presence of phosphate, an amino-to-imino tautomeric shift occurs with markedly increased affinity (Kd = 0.5 µM vs 46 µM without phosphate), demonstrating that phosphate binding modulates nucleoside binding affinity. Binding stoichiometry is one ligand per native enzyme hexamer.\",\n      \"method\": \"Steady-state and time-resolved fluorescence spectroscopy, excitation/emission/absorption spectral analysis, Stern-Volmer quenching analysis\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — multiple spectroscopic methods but single lab, mechanistic conclusions about tautomeric shifts inferred from spectra\",\n      \"pmids\": [\"10606773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"miR-1 and miR-133a directly regulate PNP expression in prostate cancer cells, as demonstrated by genome-wide gene expression analysis and luciferase reporter assay. Silencing of PNP gene inhibited proliferation, migration, and invasion of PC3 and DU145 prostate cancer cells, identifying PNP as a functional oncogenic target of these tumor-suppressor miRNAs.\",\n      \"method\": \"miRNA restoration, genome-wide gene expression analysis, luciferase reporter assay (3'UTR targeting), siRNA-mediated PNP knockdown with proliferation/migration/invasion assays\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase reporter confirms direct miRNA targeting, loss-of-function with defined cellular phenotype, single lab\",\n      \"pmids\": [\"22068816\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SAMHD1 (a dNTP hydrolase) prevents the accumulation of toxic dNTP levels during PNP inhibition, thereby protecting cancer cells from PNP inhibitor-induced cell death. Cancer cells lacking SAMHD1 are selectively killed by PNP inhibitors, establishing SAMHD1 as a resistance factor for PNP inhibitor therapy.\",\n      \"method\": \"Cell viability assays in SAMHD1-deficient vs proficient cell lines treated with PNP inhibitors\",\n      \"journal\": \"Molecular & cellular oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — cell-based assays establishing pathway relationship, single report, limited mechanistic detail in abstract\",\n      \"pmids\": [\"33235905\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human purine nucleoside phosphorylase (PNP) is a homotrimeric cytoplasmic enzyme that catalyzes the phosphorolysis of purine nucleosides (especially 6-oxopurine nucleosides in beta-configuration) to free purine bases and ribose-1-phosphate, using inorganic phosphate (preferentially in its dianionic form) as cosubstrate; the active site Glu201 plays the key catalytic role while a dynamic loop (residues 243–266) orders upon substrate binding, the enzyme exhibits negative cooperativity in phosphate binding, and its activity in T cells is essential for dGTP homeostasis—PNP deficiency or inhibition causes selective T-cell death through dGTP accumulation-triggered caspase-3-mediated apoptosis, a mechanism exploited therapeutically by transition-state analog inhibitors (immucillin-H/forodesine) whose binding is structurally defined by multiple crystal structures.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PNP is a cytoplasmic homotrimeric enzyme that catalyzes the phosphorolysis of 6-oxopurine nucleosides in the beta-configuration, recognizing the N1 and O6 positions of the purine ring as essential determinants of substrate activity, with a conserved active-site glutamate (Glu201, equivalent to Glu204 in the bacterial enzyme) serving the key catalytic role and a neighboring asparagine supporting binding of 6-oxopurines rather than catalysis [#0, #1, #5]. The dianionic form of inorganic phosphate is the preferred cosubstrate, and the enzyme exhibits negative cooperativity in phosphate binding, indicating allosteric communication between active sites [#14]. Catalysis is accompanied by ordering of a dynamic loop (residues 243\\u2013266) near the purine base upon substrate or inhibitor binding, with active-site loops coexisting in multiple conformational states in the phosphate-bound enzyme that collapse to single conformations upon transition-state-analog binding [#7, #8]. In T cells, PNP activity is essential for purine metabolism and dGTP homeostasis: enzymatic inhibition combined with deoxyguanosine drives massive dGTP accumulation that inhibits ribonucleotide reductase and triggers caspase-3-mediated apoptosis, selectively killing T-lineage leukemic cells\\u2014a vulnerability exploited by transition-state-analog inhibitors such as immucillin-H/forodesine whose binding is defined by human PNP crystal structures [#2, #4, #9]. A loss-of-function PNP variant (rs1049564) produces relative PNP deficiency, an S-phase cell cycle block reversible by hypoxanthine and adenosine, and increased type I interferon pathway activation [#10]. Beyond its canonical cytoplasmic role, PNP is constitutively released into the extracellular medium where it contributes to purinergic homeostasis, and the C. elegans ortholog pnp-1 acts in intestinal epithelium as a negative regulator of the intracellular pathogen response [#12, #13].\",\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Established what defines a PNP substrate at the chemical level, explaining the enzyme's strict requirement for 6-oxopurine nucleosides and the basis of substrate discrimination versus the promiscuous bacterial enzyme.\",\n      \"evidence\": \"Kinetic analysis of modified nucleoside analogues with mammalian and bacterial PNP\",\n      \"pmids\": [\"2109978\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Catalytic residue identities proposed but not confirmed by mutagenesis\", \"No structural model at this stage\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Defined the terminal effector pathway of PNP inhibition in T cells, showing that cell death proceeds through caspase-3-mediated apoptosis dependent on dGTP accumulation.\",\n      \"evidence\": \"Western blots for PARP and alpha-spectrin cleavage, caspase-3 activity assays, and deoxycytidine/pan-caspase rescue in T cells treated with CI-1000 plus deoxyguanosine\",\n      \"pmids\": [\"9403342\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Did not quantify the dNTP pool changes upstream of apoptosis\", \"Did not address selectivity for T cells over other lineages\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Provided the first structural mechanism for purine recognition and catalysis, identifying the phosphate-binding residues and assigning the catalytic glutamate (Glu204/Glu201) and a binding-supporting asparagine.\",\n      \"evidence\": \"X-ray crystallography of binary and ternary dead-end complexes of trimeric Cellulomonas PNP at 2.2\\u20132.4 \\u00c5\",\n      \"pmids\": [\"10600382\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Structure from a bacterial homolog rather than human enzyme\", \"Catalytic role inferred from geometry plus prior kinetics\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved the structural basis of transition-state-analog inhibition and purine binding in the human enzyme, enabling rational inhibitor design.\",\n      \"evidence\": \"X-ray crystallography of human PNP with immucillin-H and with guanine\",\n      \"pmids\": [\"13679061\", \"14680831\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Static snapshots did not capture loop dynamics\", \"Did not quantify inhibitor potency in cells\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrated that dGTP accumulation, not dATP, is the primary cytotoxic driver of PNP inhibition, mechanistically linking it to ribonucleotide reductase inhibition.\",\n      \"evidence\": \"dNTP pool analysis and deoxycytidine/lamivudine rescue in CEM-SS T-ALL cells treated with forodesine plus deoxyguanosine\",\n      \"pmids\": [\"12781704\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Restricted to a single T-ALL line\", \"Did not connect dGTP accumulation to the caspase cascade in the same assay\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Refined the substrate-binding determinants of human PNP, confirming preference for beta-configuration purine nucleosides with 6-keto groups.\",\n      \"evidence\": \"X-ray crystallography of human PNP with guanosine, 3'-deoxyguanosine, 8-azaguanine and hypoxanthine complexes\",\n      \"pmids\": [\"15983407\", \"15582582\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Did not resolve catalytic intermediates\", \"Loop dynamics not characterized\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Confirmed PNP as an intracellular cytoplasmic enzyme essential for T-cell purine metabolism by restoring function in deficient cells.\",\n      \"evidence\": \"Protein transduction of PTD-PNP into PNP-deficient lymphocytes with fractionation and T-cell functional assays\",\n      \"pmids\": [\"16930574\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Used an engineered fusion rather than endogenous protein\", \"Single-lab functional correction\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Characterized the conformational behavior of the active site, showing that the 243\\u2013266 loop becomes highly ordered upon ligand binding and that ternary complex formation does not require kinetically significant conformational changes.\",\n      \"evidence\": \"Tryptophan-free Leuko-PNP construct studied by mutagenesis, fluorescence, 13C NMR, temperature-jump, and crystallography\",\n      \"pmids\": [\"18269249\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Conducted on an engineered Trp-to-Tyr variant\", \"Did not link loop ordering to catalytic rate enhancement\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the phosphate cosubstrate chemistry, establishing the dianionic phosphate as preferred and revealing negative cooperativity indicative of inter-subunit allostery.\",\n      \"evidence\": \"pH-dependent enzyme kinetics and Hill coefficient analysis of human erythrocyte and E. coli PNP\",\n      \"pmids\": [\"17639373\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Allostery inferred from kinetics without structural validation\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showed that catalytic-site loops sample multiple conformational states in the phosphate-bound enzyme that are selected to single conformations by transition-state analogs, providing a dynamic view of inhibitor action.\",\n      \"evidence\": \"19F-NMR with site-specific 6-fluoro-tryptophan labeling combined with X-ray crystallography of multiple ligand complexes\",\n      \"pmids\": [\"23438750\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Required site-specific fluorine labeling\", \"Functional consequence of each conformer not quantified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Linked a human loss-of-function PNP variant to cell cycle disruption and innate immune dysregulation, connecting relative PNP deficiency to S-phase block and type I IFN activation.\",\n      \"evidence\": \"Genotyped lymphoblastoid lines with enzyme assays, flow cytometry, hypoxanthine/adenosine rescue, and IFN gene expression\",\n      \"pmids\": [\"28859258\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single variant in a cell-line model\", \"Mechanism linking purine deficiency to IFN activation not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified an extracellular pool of enzymatically active PNP under receptor and oxygen-state control, expanding its role into purinergic system homeostasis.\",\n      \"evidence\": \"Extracellular enzyme activity detection with P2Y1/A2A agonist pharmacology and hypoxia/re-oxygenation in C6 glioma cells\",\n      \"pmids\": [\"28251649\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single cell model\", \"Mechanism of release not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Implicated PNP as a downstream effector of tumor-suppressor miRNAs in prostate cancer, where its expression supports proliferation, migration, and invasion.\",\n      \"evidence\": \"miR-1/miR-133a restoration, luciferase 3'UTR reporter, and PNP siRNA knockdown with phenotypic assays in PC3/DU145 cells\",\n      \"pmids\": [\"22068816\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single tumor type and lab\", \"Metabolic mechanism of the oncogenic phenotype not defined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Positioned SAMHD1 as a resistance factor that buffers dNTP accumulation during PNP inhibition, defining a synthetic-lethal vulnerability in SAMHD1-deficient cancers.\",\n      \"evidence\": \"Cell viability assays in SAMHD1-deficient versus proficient lines treated with PNP inhibitors\",\n      \"pmids\": [\"33235905\"],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single report with limited mechanistic detail\", \"Direct biochemical interaction not demonstrated\", \"Not validated in vivo\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PNP's purine-base products are decoded as immune and host-defense signals\\u2014linking its catalytic output to type I IFN activation and the intracellular pathogen response\\u2014remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No defined signaling intermediate connecting purine metabolite levels to IFN induction\", \"Conservation of the host-defense role to mammals untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 5, 14]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [0, 1, 14]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [12, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 4, 12]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [4, 9]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [10, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}